Related Funds
Funds with similar focus
Fund Name | Location |
10X Capital | - |
Aol Ventures | New York, New York, United States |
Beijing Shixi Yutang Huachuang Investment Management | Beijing, Beijing, China |
Catalysta Ventures | Durham, North Carolina, United States |
Collab Capital | Atlanta, Georgia, United States |
Exome Asset Management | New York, New York, United States |
Gelt VC | California, Los Angeles, United States |
Guangzhou Chuangxi Enterprise Management | China, Guangdong, Guangzhou |
HDG Inc | Canada, Quebec, Quebec |
Interlace Ventures | New York, New York, United States |
Intuit | California, Mountain View, United States |
Provident Capital | Gurgaon, Haryana, India |
Quantum Pacific Capital | China, Hong Kong, Hong Kong Island |
R. B. Webber & Co. | California, Mountain View, United States |
Roularta Media Group | Belgium, West Flanders, West-Vlaanderen |
Telos Impact | Belgium, Brussels, Brussels Hoofdstedelijk Gewest |
TPL eVentures | - |
Vidici Ventures | - |
Vinci Partners | Brazil, Rio de Janeiro, Rio De Janeiro |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Moleculent | $26M | 11 Jun 2024 | Solna, Stockholms Lan, Sweden | ||
Hoba Therapeutics | $27M | 10 Dec 2023 | Copenhagen, Capital Region of Denmark, Denmark | ||
Henlez | $1M | 24 Oct 2022 | Copenhagen, Hovedstaden, Denmark | ||
Pretzel Therapeutics | $72M | 12 Sep 2022 | Waltham, Massachusetts, United States | ||
Synklino | $35M | 08 Jun 2022 | Denmark, Capital Region of Denmark, Denmark | ||
Scenic Biotech | $33M | 10 Mar 2022 | Amsterdam, North Holland, Netherlands | ||
IO Biotech | $149M | 13 Jan 2021 | Capital Region of Denmark | ||
Synklino | 29 Sep 2020 | Denmark, Capital Region of Denmark, Denmark |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Moleculent | $26M | 11 Jun 2024 | Solna, Stockholms Lan, Sweden | ||
Hoba Therapeutics | $27M | 10 Dec 2023 | Copenhagen, Capital Region of Denmark, Denmark | ||
Henlez | $1M | 24 Oct 2022 | Copenhagen, Hovedstaden, Denmark | ||
Pretzel Therapeutics | $72M | 12 Sep 2022 | Waltham, Massachusetts, United States | ||
Synklino | $35M | 08 Jun 2022 | Denmark, Capital Region of Denmark, Denmark | ||
Scenic Biotech | $33M | 10 Mar 2022 | Amsterdam, North Holland, Netherlands | ||
IO Biotech | $149M | 13 Jan 2021 | Capital Region of Denmark | ||
Synklino | 29 Sep 2020 | Denmark, Capital Region of Denmark, Denmark |